![Miguel Lopez-Lago](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 34 285 $ au 31/05/2026
Dr. Miguel A. Lopez-Lago is a Chief Scientific Officer at BriaCell Therapeutics Corp.
Dr. Lopez-Lago was previously employed as a Senior Research Scientist by Memorial Sloan Kettering Cancer Center.
He received his undergraduate degree from the University of Santiago de Compostela and a doctorate degree from the University of Santiago de Compostela.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/02/2026 | 9 419 ( 0,13% ) | 34 285 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BRIACELL THERAPEUTICS CORP. | Directeur Technique/Scientifique/R&D | 01/05/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Health Services |
University of Santiago de Compostela
 University of Santiago de Compostela Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BriaCell Therapeutics Corp.
 BriaCell Therapeutics Corp. BiotechnologyHealth Technology Operates as an immuno-oncology biotechnology company which develops targeted approaches for the management of breast cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
